Peritoneal Carcinomatosis and Multi-Organ Metastases are Prognostic Factors in Colorectal Cancer: A Retrospective Analysis
DOI:
https://doi.org/10.6000/1927-7229.2016.05.01.1Keywords:
Colorectal cancer, prognostic factors, peritoneal carcinomatosis, first line chemotherapy, multi-organ metastases.Abstract
Background: Peritoneal carcinomatosis and multi-organ metastases might be prognostic factors in patients with advanced colorectal cancer and inoperable metastases at diagnosis.
Methods: A retrospective study was performed to examine the relationship between patient clinical characteristics and prognosis in patients with colorectal cancer and indication for first-line systemic chemotherapy.
Results: One hundred and twelve patients were accrued. According to univariate analysis, peritoneal carcinomatosis, lack of primary tumour resection and multi-organ metastases were associated with poor overall survival. According to multivariate analysis, patients with peritoneal carcinomatosis and patients with multi-organ metastases had a shorter overall survival (12 vs 27.0 months, p<0.001 and 14,6 vs 27 months, p=0.007, respectively).
Conclusions: Our results indicate that presence of peritoneal carcinomatosis and multi-organ metastases are independent predictors of poor outcome for patients with colorectal cancer undergoing first line treatment with standard chemotherapy.
References
Surveillance, Epidemiology and End Results (SEER) Program [homepage on the Internet]. Available from www.seer.cancer.gov. Stat Database: Incidence-SEER 17. Nov 2006 Sub (1973-2004).
Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual (7th ed), Eds. New York, NY: Springer 2010; p. 143.
Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin 2012; 62(1): 10-29. http://dx.doi.org/10.3322/caac.20138
Bleiberg H. Role of chemotherapy for advanced colorrectal cancer. New oportunities. Semin Oncol 1996; 23(1 Suppl 3): 42-50.
De Gramont A, Vignoud J, Tournigand C, Louvet C, André T, Varette C, et al. Oxaliplatin with high-dose leucovorin and 5- fluorouracil 48-hours continuous infusion in preatreated metastatic colorrectal cancer. Eur J Cancer 1997; 33(2): 214-9. http://dx.doi.org/10.1016/S0959-8049(96)00370-X
Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 2001; 280(6): C1358-66.
Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9(6): 669-76. http://dx.doi.org/10.1038/nm0603-669
Jain RK. Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 2001; 7(9): 987-9. http://dx.doi.org/10.1038/nm0901-987
Kabbinavar FF, Hambleton J, Mass RD, Hurwitz HI, Bergsland E, Sarkar S. Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer. J Clin Oncol 2005; 23(16): 3706-12. http://dx.doi.org/10.1200/JCO.2005.00.232
Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350(23): 2335-42. http://dx.doi.org/10.1056/NEJMoa032691
Giantonio BJ, Catalano PJ, Meropol NJ, O'Dwyer PJ, Mitchell EP, Alberts SR, et al. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 2007; 25(12): 1539-44. http://dx.doi.org/10.1200/JCO.2006.09.6305
Saltz L, Clarke S, Diaz-Rubio E, Scheithauer W, Figer A, Wong R, et al. Bevacizumab in combination with oxaliplatinbased chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol 2008; 26(12): 2013-9. http://dx.doi.org/10.1200/JCO.2007.14.9930
Kuo LJ, Leu SY, Liu MC, Jian JJ, Hongiun Chen S, Chen CM. How aggressive should we be in patients with stage IV colorectal cancer? Dis Colon Rectum 2003; 46(12): 1646-1652. http://dx.doi.org/10.1007/BF02660770
Shah SA, Haddad R, Al-Sukhni W, Kim RD, Greig PD, Grant DR, et al. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am Coll Surg 2006; 202(3): 468-75. http://dx.doi.org/10.1016/j.jamcollsurg.2005.11.008
Leichman L. The role of chemotherapy in the curative treatment of patients with liver metastases from colorectal cancer. Surg Oncol Clin N Am 2007; 16: 537-556. http://dx.doi.org/10.1016/j.soc.2007.04.003
Shepherd NA, Baxter KJ, Love SB. The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 1997; 112: 1096-1102. http://dx.doi.org/10.1016/S0016-5085(97)70119-7
Eker B, Ozaslan E, Karaca H, Berk V, Bozhurt O, Inanc M,
et al. Factors affecting prognosis in metastatic colorectal cancer patients. Asian Pac J Cancer Prev 2015; 16: 3015-21. http://dx.doi.org/10.7314/APJCP.2015.16.7.3015
Miyamoto Y, Hayashi N, Sakamoto Y, Ohuchi M, Tokunagam R, Kurashige J, et al. Predictors of long-term survival in patients with stage IV colorectal cancer with multi-organ metastases: a single center retrspective analysis. Int J Clin Oncol 2015; published online.
Yun HR, Lee WY, Lee WS, Cho YB, Yun SH, Chun HK. The prognostic factors of stage IV colorectal cancer and assessment of proper treatment according to the patient’s status. Int J Colorectal Dis 2007; 22(11): 1301-1310. http://dx.doi.org/10.1007/s00384-007-0315-x
Mijamoto Y, Hayashi N, Sakamoto Y, Oushi M, Tokunagam R, Kurashige J. Predctors of long-term survival in patients with stage IV colorrectal cancer with multi-organ metastases: a single-center retrospective análisis. Int J Clin Oncol published online: 07 May 2015.
Chua TC, Saxena A, Liauw W, Chu F, Morris DL. Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases—a systematic review. Eur J Cancer 2012; 48(12): 1757-1765. http://dx.doi.org/10.1016/j.ejca.2011.10.034
Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 1989; 63: 364-367. http://dx.doi.org/10.1002/1097-0142(19890115)63:2<364::AID-CNCR2820630228>3.0.CO;2-V
Jimenez-Perez J, Caellas J, Garcia-Cano J, Vandervoort J, García Escribano OR, Barcenilla J, et al. Colonic Stenting as a bridge to surgery in malignant large-bowel obstruction: a report from two large multinational restries. Am J Gastroenterol 2011; 106: 2174-2180. http://dx.doi.org/10.1038/ajg.2011.360
Haslinger M. Francescutti V, Attwood K, McCart JA, Fakih M, Kane JM 3rd, et al. A contemporany análisis of morbidity and outcomes in cytoredution/hyperthermic intraperitoneal chemoperfusion. Cancer Medicine 2013; 2: 334-342.
Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and pallliative surgery in patietns with peritoneal carcinomatosis of colorrectal cancer. J Clin Oncol 2003; 21: 3737-3743. http://dx.doi.org/10.1200/JCO.2003.04.187
Downloads
Published
Issue
Section
How to Cite
Similar Articles
- Guan Min Lai, Jen-Tsun Lin , Cheng-Shyong Chang , Metastatic Bone Marrow Tumors Manifested by Hematologic Disorders: Study of Thirty-Four Cases and Review of Literature , Journal of Analytical Oncology: Vol. 3 No. 4 (2014)
- Mª José Safont, Jorge Aparicio, Alejandra Giménez Ortiz, José Mir, Eva Montalvá, Miriam Cantos Pallarés, Preoperative Chemotherapy Plus Bevacizumab and Morbidity after Resection of Colorectal Cancer Liver Metastases , Journal of Analytical Oncology: Vol. 3 No. 1 (2014)
- Aradhana Mohan, S.L. Pranitha, S. Arpitha, S.N. Geeta, Sushmitha K. Thomas, Prognostic Factors Affecting the Overall Survival and Disease-Free Survival in Carcinoma Lung Patients Treated with Sequential Chemoradiation and Concurrent Chemoradiation: A Retrospective Study , Journal of Analytical Oncology: Vol. 14 (2025)
- Javier Garde Noguera, Elena Evgenyeva, Mireia Gil Raga, Asunción Juárez Marroquí, Juan Manuel Gasent Blesa, Juan Laforga, Laia Bernet, Mónica Clemente Císcar, Carlos Camps Herrero, Antonio Llombart Cussac, Role of Primary Tumour Resection and Addition of Bevacizumab to Chemotherapy in the Management of Advanced Colorectal Cancer with Inoperable Metastasis: A Retrospective Analysis , Journal of Analytical Oncology: Vol. 2 No. 4 (2013)
- Kenji Ina, Ryuichi Furuta, Takae Kataoka, Sayaka Sugiura, Satoshi Kayukawa, Takayuki Kanamori, Takaki Kikuchi, Megumi Kabeya, Satoshi Hibi , Shu Yuasa , Adverse Effects of Bevacizumab During Treatment for Metastatic Colorectal Cancer , Journal of Analytical Oncology: Vol. 4 No. 1 (2015)
- Mireia Gil-Raga, Javier Garde-Noguera, Advanced Colorectal Cancer , Journal of Analytical Oncology: Vol. 5 No. 1 (2016)
- Hiroko Ina, Kenji Ina, Megumi Kabeya, Satoshi Kayukawa, Takashi Yoshida, Masahiko Yoneda, Lentinan, a Shiitake Mushroom ß-Glucan, Downregulates the Enhanced PD-L1 Expression Induced by Platinum Compounds in Gastric Cancer Cells - , Journal of Analytical Oncology: Vol. 9 (2020)
- Hassan Akbari, Farzad Taghizadeh Hesary, Laya Rahnar Nikoukar, Distribution of Breast Cancer Biomarkers by Age in Iran , Journal of Analytical Oncology: Vol. 6 No. 1 (2017)
- Vu Hong Thang, Lambert Skoog, Nguyen Ba Duc, Ta Thanh Van, Edneia Tani , Cell Proliferation Measured by Ki67 Staining and Correlation to Clinicopathological Parameters in Operable Breast Carcinomas from Vietnamese and Swedish Patients , Journal of Analytical Oncology: Vol. 4 No. 2 (2015)
- Sajad Ahmad Salati, Mohammed Alfehaid, Lamees Sulaiman Alsulaim, Saleh Ahmad Alsuwaydani, Mohammed Ahmed Elmuttalut, Uterine Metastasis from Carcinoma of Breast – A Systematic Analysis , Journal of Analytical Oncology: Vol. 12 (2023)
You may also start an advanced similarity search for this article.
Most read articles by the same author(s)
- Omar Youssef, Virinder Kaur Sarhadi, Lauri Lehtimäki, Milja Tikkanen, Arto Kokkola, Pauli Puolakkainen, Gemma Armengol, Sakari Knuutila, Mutations by Next Generation Sequencing in Stool DNA from Colorectal Carcinoma Patients - A Literature Review and our Experience with this Methodology , Journal of Analytical Oncology: Vol. 5 No. 1 (2016)